CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 162 enrolled
Drug / intervention
Pantheris Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01937351
NCT01937351N/ACompleted

Evaluation of the Pantheris Optical Coherence Tomography Imaging Atherectomy System for Use in the Peripheral Vasculature

Avinger, Inc.·interventional·Posted Sep 9, 2013·Updated Mar 25, 2021

In Brief

A clinical study evaluating Pantheris System for Peripheral Arterial Disease. Completed, enrolled 162 participants across 21 sites in 2 countries.

Detailed Summary

A non-randomized, prospective, global clinical trial of the Avinger Pantheris System, an atherectomy device that provides directional visualization and imaging as an adjunct to fluoroscopy to aid removal of plaque in diseased lower extremity arteries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGermany, United States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 9, 2013
Enrollment StartJun 25, 2013
Primary CompletionJul 15, 2015
Study CompletionSep 20, 2015
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 12.8 years ago

Interventions

Pantheris Systemdevice

Atherectomy using directional visualization and imaging as an adjunct to fluoroscopy to aid removal of plaque from diseased lower extremity arteries.